Jeremy Pfeffer
Managing Director, LifeSci Advisors
Replay available
TriSalus Life Sciences, Inc. (TLSI) Q1 2026 Earnings Call
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Mary Della
President and Chief Executive Officer, Trisalis Life Sciences
David Patience
Chief Financial Officer, Trisalis Life Sciences
Frank DeKinney
Analyst, Lake Street Capital Markets
William Blavonic
Analyst, Kennicore Genuity
Justin Walsh
Analyst, Jones Trading
Dr. Richard Marshall
Medical Director, Trisalis Life Sciences
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Trisalus Life Sciences, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.837 Good afternoon and welcome to the Trisalis Life Sciences first quarter 2026 earnings 00:00:05.837 -- 00:00:10.923 conference call. All participants are currently in a listen-only mode. 00:00:10.923 -- 00:00:15.908 Following management's prepared remarks, we will hold a question and answer session. 00:00:15.908 -- 00:00:19.692 As a reminder, this call is being recorded for replay purposes. 00:00:19.692 -- 00:00:25.118 I will now turn the call over to Jeremy Pfeffer, Managing Director with LifeSci Advisors. 00:00:25.118 -- 00:00:27.539 Please go ahead. 00:00:28.853 -- 00:00:32.177 Thank you, Operator, and thank you all for joining us today. 00:00:32.177 -- 00:00:37.163 With me from Trisalis Life Sciences are Mary Della, President and Chief Executive Officer, 00:00:37.163 -- 00:00:40.748 David Patience, Chief Financial Officer, and Dr. 00:00:40.748 -- 00:00:43.571 Richard Marshall, Medical Director. 00:00:43.571 -- 00:00:47.576 Mary will provide an overview of our first quarter results and our strategy for the balance 00:00:47.576 -- 00:00:51.822 of the year. David will then walk through the financial results in detail. 00:00:51.822 -- 00:00:56.512 Dr. Marshall will join Mary and David for the Q&A portion of the call. 00:00:56.512 -- 00:01:00.576 Earlier today, Trisalis released its financial results for the quarter ended March 31, 00:01:00.576 -- 00:01:02.518 2026. 00:01:02.518 -- 00:01:07.544 A copy of the press release is available on the Trisalis Investor Relations website. 00:01:07.544 -- 00:01:12.049 Today, Trisalis also announced the publication of a landmark real-world evidence study 00:01:12.049 -- 00:01:16.654 evaluating the clinical and economic impact of our pressure-enabled drug delivery, or 00:01:16.654 -- 00:01:22.059 P...